20% sequential quarterly revenue growth and 91% year-over-year quarterly gross profit growth Continued momentum from recurring higher-margin cartridge sales now reaching 58% of total sales for the nine months ended March 31, 2025 35 new accounts and international growth during Q3 bring total active accounts to over 450 NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive t ...

MENLO PARK, Calif., May 12, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced a new partnership with athenahealth, a leading provider of network-enabled software and services for healthcare practices and systems nationwide. This collaboration will integrate ordering of GRAIL's Galleri® multi-cancer early detection (MCED) test into athenaCoordinator Core, a service designed to help streamline laboratory order tr ...

Core Insights - Advantest Corporation will showcase its latest semiconductor test solutions at SEMICON Southeast Asia 2025, emphasizing its commitment to becoming the most trusted and valued test solution provider in the semiconductor value chain [1] Product and Solution Highlights - Advantest will present a diverse range of solutions aimed at addressing technology challenges in high-performance computing (HPC), AI, automotive, and 5G/IoT, while supporting technologies like silicon photonics and high-bandwidth memory (HBM) [2] - Key product highlights include the new SiConic solution for automated silicon validation, enhancements to the V93000 EXA Scale test system, and the ACS Real-Time Data Infrastructure (ACS RTDI™) for optimizing production processes [6] Presentations - Advantest will participate in the AI for Advanced Product Testing Forum, where a presentation on optimizing semiconductor testing with AI and digital twin technologies will be delivered by Don Ong [3] Company Overview - Advantest is a leading manufacturer of automatic test and measurement equipment for semiconductors, with applications in 5G, IoT, autonomous vehicles, and AI, and is committed to sustainable practices and social responsibility [5]

据了解，米飞泰克于2022年11月21日启动IPO辅导，而本期辅导期间为2025年1月1日至2025年3月31 日。 公开资料显示，米飞泰克成立于2018年3月，注册资本约1.92亿元，国家级高新技术企业，专业从事集 成电路封装及测试，是广东省科技厅认定的广东省集成电路先进封测工程技术研究中心。 目前，公司拥有64项专利以及机器人和自动化设备研发部门，提供晶圆到模组一站式制造服务，包括切 磨分拣、晶圆测试、IC封装和一系列配套服务。 值得一提的是，米飞泰克的董事长兼首席执行官为李安平，其于1994年深圳出生，海归学霸。 瑞财经 吴文婷近日，深圳米飞泰克科技股份有限公司(以下简称"米飞泰克" )披露IPO辅导工作进展情况 报告（第十期），辅导机构为中信证券股份有限公司(以下简称"中信证券")。 图片来源：深圳市南山外国语学校（集团）沙河小学官微 据深圳市南山外国语学校（集团）沙河小学的官微披露，2024年9月25日，南外（集团）沙河小学正式 聘请深圳米飞泰克科技有限公司董事长李安平女士担任学校科学副校长一职。 该学校指出，李安平女士不仅是深圳米飞泰克科技股份有限公司的董事长兼首席执行官，更是一位杰出 的科技企业 ...

一旦量子计算规模化应用，强大的量子计算能力分分钟就能破解传统的加密体系。如此一来，人们的数 据难道要进入"裸奔"状态？数据传输的安全性如何保障？在隔壁的问天量子展台，记者找到了答案。 转自：北京日报客户端 国内首个突破千比特规模的光量子计算机，北京首个由区政府、高校和市属企业深度联合打造的环高校 创新区，一键连接十多家全国主流大模型的AI搜索……5月8日至11日举行的北京科博会上，朝阳展区 20家优质企业、平台组团亮相，从人工智能、未来产业、科创平台三大板块集中展现朝阳在科技创新与 应用方面的新成果、新突破，绘制科技与未来交织的画卷。 前沿企业追踪未来"密码" 在朝阳展区，一台闪着蓝色光波的设备吸引了众多观众驻足。这台由玻色量子首次展出的1000量子比特 相干光量子计算机，是国内首个突破千比特规模的专用光量子计算机。玻色量子创始人、CEO文凯 说，"在生物制药领域，对于小分子库筛选过程，在经典计算机上可能需要数天甚至数月的时间，通过 这台相干光量子计算机只需要毫秒级。药物筛选可实现至少数千倍加速，预期在生物制药领域可极大提 升小分子筛选的计算效率。" 山河湾谷创新区、中关村互联网3.0产业园、北京市数字人基地 ...

Veracyte, Inc. (VCYT) delivered first-quarter 2025 earnings of 31 cents per share, which marked a stupendous improvement of 63.2% from the year-ago period’s figure of 19 cents. The bottom line beat the Zacks Consensus Estimate by 55%.The company-adjusted earnings per share (EPS) were 9 cents compared to the year-ago period’s loss of 2 cents per share. Following the earnings announcement, VCYT’s share price gained 1.2% yesterday. VCYT’s Q1 RevenuesRevenues increased 18.3% year over year to $114.5 million, wh ...

| 序号 | 股东名称 | 持股份数量(股) | 占公司总股本比 கு | 备注 | | --- | --- | --- | --- | --- | | | 银圣宇 | 15,519,504 | 7.76% | 持股 5%以上 | | 2 | 袁凤江 | 1,555,648 | 0.78% | 董事、总经 | | 3 | 赵秀珍 | 1.958.549 | 0.98% | 董事、副总经理、 | | चे | 张国光 | 1.033.368 | 0.52% | 董事、副总经理、] | | 5 | 李永新 | 951,295 | 0.48% | 版事 | 图片系AI生成 在半导体复苏的曙光中，5月7日晚，蓝箭电子（301348.SZ）股东开启上市两年来第三次密集减持，公司三股东及4名高管拟合计减持337.74万股，占比 1.68%，减值市值约8011.15万元。 此次减持，无疑将再度让市场对其未来发展投以审视目光，尤其面对封测三巨头的强势扩张，昔日"小巨人"遭遇的围剿或将愈演愈烈。在蓝箭电子时值戴维 斯双杀，深陷泥沼难突围战的当下，这并非是个乐观的信号。 股东及高管再度减持 公告显示，蓝箭电子第三大股东上海银圣宇 ...

Mistras Group (MG) Q1 2025 Earnings Call May 08, 2025 09:00 AM ET Company Participants Thomas Tobolski - TreasurerNatalia Shuman - President & CEOEdward Prajzner - Senior EVP & CFOMitchell Pinheiro - Director - Research Conference Call Participants John Franzreb - Senior Equity AnalystChristopher Sakai - Analyst Operator Good day, everyone. My name is Abigail, and I will be your conference operator today. At this time, I would like to welcome you to Mistras Group Inc q one twenty twenty five earnings call. ...

Financial Data and Key Metrics Changes - Revenue decreased by over 12% year-over-year, primarily due to market uncertainty, with a notable decline of $16.6 million in the oil and gas end market [10][11] - The company reported a GAAP net loss of $3.2 million or $0.10 per share, while the non-GAAP net loss was $0.01 per share for the first quarter [18] - Adjusted EBITDA decreased by $4.2 million to $12 million, marking the second highest first quarter adjusted EBITDA performance in the last five years [18] - Net cash provided by operating activities was $5.6 million, an increase of $5 million compared to the prior year [19] Business Line Data and Key Metrics Changes - The oil and gas end market experienced the largest revenue decline, particularly in the downstream sector, attributed to timing of turnarounds and project delays [10][11] - Aerospace and defense revenue declined by $1.7 million due to macroeconomic uncertainties and supply chain disruptions [11][12] - The Data Solutions Group, particularly the PCMS offering, saw a revenue growth of 6% compared to the prior year [13] Market Data and Key Metrics Changes - The international segment revenue increased by nearly 4% in local currency, although this was offset by adverse foreign exchange translation [16] - The company noted a reduction in customer spending and project pushouts in upstream and midstream sub-industries due to market uncertainties [11] Company Strategy and Development Direction - The company is focusing on three key initiatives: leadership talent evaluation, recalibration of cost base, and developing growth strategies across all businesses [6][7] - Mistras is emphasizing accelerated expansion in core end markets like oil and gas and aerospace and defense, with a focus on integrated solutions leveraging data analytics [7][9] - The launch of the Mistras Data Solution brand consolidates data-centric services and technologies, aiming to enhance operations for asset-intensive end markets [10] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism for the remainder of the year despite a slower start in key markets, with expectations of recovering revenue in the oil and gas sector [11][12] - The company is closely monitoring potential industry headwinds caused by global market uncertainties and tariffs [12][23] - Management anticipates that adjusted EBITDA for 2025 will at least meet or exceed the levels achieved in 2024 [24] Other Important Information - The company is not providing full-year guidance for fiscal 2025 due to unprecedented market uncertainty [23] - The effective tax rate for the first quarter was a tax benefit of 26.9%, with an anticipated rate of approximately 25% for the full year [20] Q&A Session Summary Question: Changes in the operating environment compared to three months ago - Management noted unprecedented uncertainty affecting project delays and customer evaluations regarding tariffs [33][34] Question: Impact of tariffs on business and project delays - The direct impact of tariffs on Mistras is minimal, but customers are pausing or delaying spending due to economic conditions [42] Question: Pricing initiatives and customer discussions - The company is maintaining commercial discipline and reviewing contract economics to ensure fair ROI for services [37][38] Question: Outlook on midstream and downstream markets - Revenue reduction in midstream is attributed to budget restrictions and regulatory drivers, with expectations of demand recovery later in the year [53] Question: Expectations for revenue and EBITDA - Management indicated that adjusted EBITDA is expected to be similar to last year, suggesting that revenue may not be significantly lower than the previous year [55][56]

CARLSBAD, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced the pricing of its previously announced underwritten public offering of 3,350,000 shares of its common stock at a public offering price of $5.25 per share. All of the shares in the offering will be sold by Exagen, with gross proceeds to Exagen expected to be $17,587,500 before deducting underwriting discounts and commissions and offering expenses. Exagen has grant ...